A Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassaemia.

NCT05752123 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Development plan change

Conditions

Transfusion Dependent Beta-Thalassaemia

Interventions

BIOLOGICAL: ET-01

Sponsor

EdiGene (GuangZhou) Inc.

Collaborators

[object Object]